Skip to main content
SpringerLink
Log in

Overview of Stone Prevention Strategies in China

  • Chapter
  • First Online:
Urolithiasis

  • 143 Accesses

Abstract

Depending upon the type of stone formed, preventative strategies can be designed to assist the patient in preventing recurrences. However, the universally applicable principle is the production of large volumes of urine, through liberal water intake, and a judicious balanced diet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hess B, Mauron H, Ackermann D, Jaeger P. Effects of a ‘common sense diet’ on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur Urol. 1999;36(2):136–43.

    Article  PubMed  CAS  Google Scholar 

  2. Borghi L, Meschi T, Schianchi T, Briganti A, Guerra A, Allegri F, et al. Urine volume: stone risk factor and preventive measure. Nephron. 1999;81 Suppl 1:31–7.

    Article  PubMed  CAS  Google Scholar 

  3. Finkielstein VA, Goldfarb DS. Strategies for preventing calcium oxalate stones. CMAJ. 2006;174(10):1407–9.

    Article  PubMed  Google Scholar 

  4. McCormack M, Dessureault J, Guitard M. The urine specific gravity dipstick: a useful tool to increase fluid intake in stone forming patients. J Urol. 1991;146(6):1475–7.

    PubMed  CAS  Google Scholar 

  5. Rodgers A. Effect of cola consumption on urinary biochemical and physicochemical risk factors associated with calcium oxalate ­urolithiasis. Urol Res. 1999;27(1):77–81.

    Article  PubMed  CAS  Google Scholar 

  6. Seltzer MA, Low RK, McDonald M, Shami GS, Stoller ML. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol. 1996;156(3):907–9.

    Article  PubMed  CAS  Google Scholar 

  7. Wabner CL, Pak CY. Effect of orange juice consumption on urinary stone risk factors. J Urol. 1993;149(6):1405–8.

    PubMed  CAS  Google Scholar 

  8. McHarg T, Rodgers A, Charlton K. Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU Int. 2003;92(7):765–8.

    Article  PubMed  CAS  Google Scholar 

  9. Straub M, Hautmann RE. Developments in stone prevention. Curr Opin Urol. 2005;15(2):119–26.

    Article  PubMed  Google Scholar 

  10. Tiselius HG. Epidemiology and medical management of stone ­disease. BJU Int. 2003;91(8):758–67.

    Article  PubMed  Google Scholar 

  11. Delvecchio FC, Preminger GM. Medical management of stone ­disease. Curr Opin Urol. 2003;13(3):229–33.

    Article  PubMed  Google Scholar 

  12. Tiselius HG. Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease. BJU Int. 2001;88(2):158–68.

    Article  PubMed  CAS  Google Scholar 

  13. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77–84.

    Article  PubMed  CAS  Google Scholar 

  14. Reddy ST, Wang CY, Sakhaee K, Brinkley L, Pak CY. Effect of low-carbohydrate high-protein diets on acid–base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis. 2002;40(2):265–74.

    Article  PubMed  CAS  Google Scholar 

  15. Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M. Guidelines on urolithiasis. Eur Urol. 2001;40(4):362–71.

    Article  PubMed  CAS  Google Scholar 

  16. Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66(6):2402–10.

    Article  PubMed  CAS  Google Scholar 

  17. Hiatt RA, Ettinger B, Caan B, Quesenberry Jr CP, Duncan D, Citron JT. Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol. 1996;144(1):25–33.

    Article  PubMed  CAS  Google Scholar 

  18. Baxmann AC, De O G Mendonça C, Heilberg IP. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int. 2003;63(3):1066–71.

    Article  PubMed  CAS  Google Scholar 

  19. Auer BL, Auer D, Rodgers AL. The effect of ascorbic acid ­ingestion on the biochemical and physicochemical risk factors associated with calcium oxalate kidney stone formation. Clin Chem Lab Med. 1998;36(3):143–7.

    Article  PubMed  CAS  Google Scholar 

  20. Ohkawa M, Tokunaga S, Nakashima T, Orito M, Hisazumi H. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol. 1992;69(6):571–6.

    Article  PubMed  CAS  Google Scholar 

  21. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997;158(6):2069–73.

    Article  PubMed  CAS  Google Scholar 

  22. Abdulhadi MH, Hall PM, Streem SB. Can citrate therapy prevent nephrolithiasis? Urology. 1993;41(3):221–4.

    Article  PubMed  CAS  Google Scholar 

  23. Jendle-Bengten C, Tiselius HG. Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate. Scand J Urol Nephrol. 2000;34(1):36–41.

    Article  PubMed  CAS  Google Scholar 

  24. Whalley NA, Meyers AM, Martins M, Margolius LP. Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia. Br J Urol. 1996;78(1):10–4.

    Article  PubMed  CAS  Google Scholar 

  25. Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986;315(22):1386–9.

    Article  PubMed  CAS  Google Scholar 

  26. Holmes RP. Pharmacological approaches in the treatment of primary hyperoxaluria. J Nephrol. 1998;11 Suppl 1:32–5.

    PubMed  Google Scholar 

  27. Cao ZG, Liu JH, Zhou SW, Wu W, Yin CP, Wu JZ. The effects of the active constituents of Alisma orientatis on renal stone formation and bikunin expression in rat urolithiasis model. Natl Med J China. 2004;84(15):1276–9.

    CAS  Google Scholar 

  28. Li HY, Liu JH, Cao ZG, Wang SG, Cai D, Ye ZQ, et al. An in vitro and in vivo study of water and lipid soluble extracts from Alisma orientatis on urinary oxalate calcium stone formation. Chin J Urol. 2003;24(10):658–62.

    Google Scholar 

  29. Wang YQ, Zhu BJ, An RH, Qi YC, Li CC. Inhibitory effect of desmodium styracifolium injection on calcium oxalate renal stone formation. Chin J Urol. 1999;20(11):689–91.

    Google Scholar 

  30. Coe FL. Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 1983;24(3):392–403.

    Article  PubMed  CAS  Google Scholar 

  31. Lewis AS, Murphy L, McCalla C, Fleary M, Purcell S. Inhibition of mammalian xanthine oxidase by folate compounds and amethopterin. J Biol Chem. 1984;259(1):12–5.

    PubMed  CAS  Google Scholar 

  32. Barbey F, Joly D, Rieu P, Méjean A, Daudon M, Jungers P. Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol. 2000;163(5):1419–23.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, People’s Republic of China

    Zhiqiang Chen M.D., Ph.D.

Authors
  1. Zhiqiang Chen M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhiqiang Chen M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Surgery Section of Urology, Aga Khan University, Stadium Road, P.O. Box 3500, Karachi, 74800, Pakistan

    Jamsheer J. Talati

  2. Karolinska Institutet, Solnavägen 1, Solna, Stockholm, 171 77, Sweden

    Hans-Goran Tiselius

  3. , Syracuse University, Crouse Hospital, 1226 East Water Street, New York, 13210, New York, USA

    David M. Albala

  4. , Department of Urology, Tongji Hospital, 1095 Jiefang Avenue, Wuhan, 430030, China, People's Republic

    ZHANGQUN YE

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

Chen, Z. (2012). Overview of Stone Prevention Strategies in China. In: Talati, J., Tiselius, HG., Albala, D., YE, Z. (eds) Urolithiasis. Springer, London. https://doi.org/10.1007/978-1-4471-4387-1_87

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4387-1_87

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4383-3

  • Online ISBN: 978-1-4471-4387-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation